Editor:
Cristophe Nicot: Kansas University Medical Center, USA
Submission Status: Open | Submission Deadline: 15th October 2023
Molecular Cancer is calling for submissions to our Collection on 'Phase 2 and 3 studies.' Topics of interest include original reports on human clinical trials phase 2 and phase 3 as well as reviews of recently reported clinical trials.